Genalyte Obtains FDA Emergency Use Authorization for Rapid COVID-19 Antibody Test
Instrument-Based, Rapid Test Uses Multi-Antigen Approach; Achieves Best-in-Class Sensitivity and Specificity San Diego (October 15, 2020) – Genalyte, a leading point-of-care diagnostics and analytics company, announced today its SARS-CoV-2 Multi-Antigen Serology Panel...
Genalyte Appoints Ashraf Hanna, M.D., Ph.D., as Chief Executive Officer
San Diego, (October 13, 2020) – Genalyte, a leading point of care diagnostics and analytics company, announced today the appointment of Ashraf Hanna, M.D. Ph.D, as CEO. “The selection of Dr. Hanna as CEO reflects Genalyte’s transition to the next phase of the...
Genalyte Expands COVID-19 Antibody Testing To Del Mar Fairgrounds
Antibody Testing Efforts Continue to Expand Throughout San Diego With New Site Opening July 15 July 15, 2020 (San Diego, CA) – San Diego-based healthcare analytics and diagnostics company, Genalyte, today announced the opening of a new COVID-19 antibody testing...
Genalyte Expands Testing Capabilities to Houston With COVID-19 Antibody Testing
Company Makes Serology Testing More Widely Available in Houston as Coronavirus Cases Continue to Surge San Diego, July 14, 2020 — Genalyte, the company empowering physicians and patients with real-time diagnostics and healthcare analytics, today announced its...
Coronavirus Survivor Determined to Help Others Stricken With Virus
A San Diego musician who contracted COVID-19 in March is now donating his plasma in the hope that his antibodies will help others stricken with the virus. Drew Andrews, 41, contracted the virus March 22 and self-quarantined at his Lemon Grove home for 14 days. On...